Health tech startup Ubie raises $19 million in Series C

113
2
Health tech startup Ubie raises $19 million in Series C

It was in the middle of the night and you couldn't reach your doctor. What is the best way to find possible causes for free in just three minutes? That is exactly what this health tech startup has done.

A Tokyo-based startup, Ubie, was founded by doctors. With an easy 3 minute questionnaire, Ubie's AI-powered AI-powered symptom checker app will generate a free report on possible causes. The Ubie team collaborated with experienced doctors and medical institutions to help people find the right medical care for their symptom checker, in order to constantly improve its AI-powered symptom checker.

To expand its global reach, Ubie closed a $19 million extension to its previous Series C round. The new cash infusion brings its total funding to $45.2 million in Series C. The new funding will enable Ubie to increase its growth and strengthen its presence in the U.S. after strong interest and traction in that market. Since its inception in 2017 Ubie has raised $76 million. Ubie didn't say anything about its valuation.

The extension round money was back with funding from LTD. AAIC Investment Pte. Loans from the Shoko Chukin Bank, the Japan Finance Corporation, and Mizuho Bank were extended while loans were extended from Ltd. Japan Impact Investment II Limited Partnership, and Rakuten Capital.

Ubie, founded in 2017 by medical doctor Yoshinori Abe and engineer Kota Kubo, is one of Japan's top-growing startups in the healthcare space. Ubie currently provides its services in Japan, the United States, and other countries around the world.

Kubo said that the information extracted from more than 50,000 clinical exploration papers created by more than 50 physicians computer-based intelligence Monshin automatically chooses and makes an inquiry or two 20 inquiries from 3,500 kinds of inquiry information.

The current healthcare system is suffering from various losses due to the fragmentation of information held by patients, medical institutions, and pharmaceutical companies, according to Yoshinori Abe, MD, co-founder and CEO of Yoshinori Abe, MD. This fundraising goal is to increase collaboration with pharmaceutical companies and create a consumer-centered medical experience using Ubie's data platform. Ubie already has business with more than 20 major pharmaceutical companies in Japan and other countries, and this brings it closer to realizing its mission to develop a healthcare guide for everyone, both in Japan and the U.S. More than 1,100 medical institutions in Japan use the AI Monshin, according to the startup. Ubie has more than 7 million monthly active users MAUs of its symptom checker app. Ubie employs about 200 people.

Ubie is one of the few companies in the world with direct contact with patients and medical institutions. The AI-based symptom checker Ubie is the gateway to medical care, with AI as its core technology.